AlphaGraphs
Bristol-Myers lets go of psoriasis drug to save Celgene merger; stock falls
The planned merger between pharmaceutical firms Bristol-Myers Squibb Company (NYSE: BMY) and Celgene (CELG) – touted as a landmark deal…
Earnings preview: Rite Aid unlikely to deliver any surprise in Q1
Rite Aid Corporation (NYSE: RAD) was on the verge of being delisted after the stock price slipped to a record…
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot…
Earnings preview: Cons outweigh the pros as FedEx gets ready for Q4 report
When FedEx Corporation (NYSE: FDX) reports fourth-quarter report Monday afternoon, after an unimpressive start to the year, it will likely…
Uncertainty looms over T-Mobile-Sprint merger as opposition mounts
The long-pending merger between telecom firms T-Mobile (Nasdaq: TMUS) and Sprint (NYSE: S) suffered a fresh setback this week after…
Earnings preview: Cost pressure to dampen General Mills’ Q4 prospects
Food company General Mills, Inc (NYSE: GIS), the maker popular brands like Cheerios and Natural Valley, is scheduled to publish…
CarMax Q1 profit rises 12%, beats estimates
CarMax Inc. (NYSE: KMX) reported a 12% jump in earnings for the first quarter of 2020 driven by strong conversion,…
Can Walgreens and CVS Health resist the online invasion of pharmacy sector?
A research report that came out recently predicted that the online pharmacy market is set to grow to $85 billion…